Innovation Pharmaceuticals Inc (IPIX)

[MackG]

IPIX + BeaMed = OPPORTUNITY:
The following information is taken from Innovation Pharmaceuticals (IPIX) Press Releases:

"Following the closing under the Purchase Agreement in June, 2022, IPIX owns approximately 35.7% of BT BeaMedical Technologies, LTD (formerly known as Squalus Medical Ltd.) outstanding equity securities and approximately 41.6% of BeaMed's equity securities on a fully diluted basis."

IPIX investors can read about BeaMed's rapid advance of its new image guided surgical laser platform for treating previously inoperable cases of epilepsy and for enabling new treatment options for cancer cases in multiple specialties. Aside from the many exciting things going on with Brilacidin, I believe that being able to buy into BeaMed via IPIX for a couple of pennies per share is an amazing investment opportunity. If you have questions about this subject, go to IPIX press releases and BeaMed's website to due your own due diligence and to get answers to any questions you may have.